These modern treatments – including copyright and Semaglutide – represent a growing class of drugs called incretin mimetics. They work by imitating the body’s natural hormone , glucagon-like peptide-1 ( https://www.heyfuturenexus.com/sites/detail/?p=What-Research-Shows-About-GLP-1-Long-term-Side-Effects-in-2026-ACBMjBYaYfrIX